logo
logo
Sign in

Immunohistochemistry Antibodies are Fastest Growing Segment Fueling the Growth of Immunohistochemistry Market

avatar
Niranjan Mardakar
Immunohistochemistry Antibodies are Fastest Growing Segment Fueling the Growth of Immunohistochemistry Market

The global Immunohistochemistry Market is estimated to be valued at US$ 1560.2 Mn or Bn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Immunohistochemistry is a technique that utilizes the principle of antibodies binding specifically to antigens to identify cell proteins in tissue sections and cells. The technique plays a vital role in cancer research, diagnosis, and treatment through visualization of antigens/proteins in cells of a tissue sample by detecting biomolecules.

Market key trends:

Immunohistochemistry antibodies have emerged as the key growing segment driving the revenue growth of the overall immunohistochemistry market. The antibody segment is projected to expand at a CAGR of 8.5% during the forecast period. Rising demand for protein biomarkers and growing application areas of antibodies have boosted the development and adoption of various types of antibodies for research and diagnosis. Moreover, technological advancements including development of fully automated high-throughput systems have improved the use of antibodies for biomarker detection on tissue slides.

Segment Analysis

The Global Immunohistochemistry Market Size is segmented into product, application, end user and region. Based on product, reagents segment dominates the market owing to rising use of reagents in antibody-based biomarker assays for disease diagnosis and research applications. The reagents segment is further sub-segmented into primary antibodies, secondary antibodies, and enzyme labels. By application, oncology segment dominates the market due to increasing prevalence of cancer worldwide. In terms of end user, hospitals and diagnostic laboratories segment holds the major market share due to increased number of hospitals and diagnostics centers worldwide performing IHC tests for disease diagnosis.

Key Takeaways

The global immunohistochemistry market is expected to witness high growth, exhibiting a CAGR of 6.6% over the forecast period, due to increasing prevalence of chronic diseases such as cancer.

North America leads the global immunohistochemistry market, owing to growing geriatric population, increasing healthcare expenditure and growing demand for precision medicine. Asia Pacific is expected to grow at the highest CAGR during the forecast period due to rising healthcare expenditure and presence of immense opportunities for market growth in emerging countries such as India and China.

Key players operating in the immunohistochemistry market are Merck KGaA, Rockland Immunochemicals, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB, Agilent Technologies, Inc., Abcam plc., Becton, Dickinson and Company, Miltenyi Biotec, Biocare Medical, LLC, Eagle Biosciences, Inc., Bio-Techne, Diagnostic Biosystems, Inc., and BioGenex. These players are adopting various inorganic and organic strategies to expand their global footprints and product portfolios to meet the growing end user demand for immunohistochemistry techniques.


Read Our More Blogs : https://www.rapidwebwire.com/immunohistochemistry-market-size-share-analysis-2023-2030/

collect
0
avatar
Niranjan Mardakar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more